Methodology to determine duration of action for antihypertensive drugs.
about
A review of telmisartan in the treatment of hypertension: blood pressure control in the early morning hoursAmbulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZThe role of ambulatory blood pressure monitoring compared with clinic and home blood pressure measures in evaluating moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocUse of ambulatory blood pressure monitoring to guide hypertensive therapy.
P2860
Methodology to determine duration of action for antihypertensive drugs.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Methodology to determine duration of action for antihypertensive drugs.
@ast
Methodology to determine duration of action for antihypertensive drugs.
@en
Methodology to determine duration of action for antihypertensive drugs.
@nl
type
label
Methodology to determine duration of action for antihypertensive drugs.
@ast
Methodology to determine duration of action for antihypertensive drugs.
@en
Methodology to determine duration of action for antihypertensive drugs.
@nl
prefLabel
Methodology to determine duration of action for antihypertensive drugs.
@ast
Methodology to determine duration of action for antihypertensive drugs.
@en
Methodology to determine duration of action for antihypertensive drugs.
@nl
P2093
P2860
P356
P1476
Methodology to determine duration of action for antihypertensive drugs.
@en
P2093
Jean Lefebvre
Luc Poirier
Yves Lacourcière
P2860
P304
P356
10.1345/APH.10367
P407
P577
2002-05-01T00:00:00Z